{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:25:03Z","timestamp":1777533903061,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.neuropharm.2017.07.018","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T22:15:54Z","timestamp":1500502554000},"page":"99-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2"],"prefix":"10.1016","volume":"125","author":[{"given":"Luc\u00eda","family":"Villarejo-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bartolom\u00e9-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Zafra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Lapunzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-4241","authenticated-orcid":false,"given":"Beatriz","family":"L\u00f3pez-Corcuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.07.018_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-6147(02)00038-X","article-title":"Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family","volume":"24","author":"Abbracchio","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib3","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1523\/JNEUROSCI.5555-12.2013","article-title":"Rapid, activity-independent turnover of vesicular transmitter content at a mixed glycine\/GABA synapse","volume":"33","author":"Apostolides","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2003.08.074","article-title":"Structure, function and regulation of glycine neurotransporters","volume":"479","author":"Aragon","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.tips.2005.04.007","article-title":"Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion","volume":"26","author":"Aragon","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib6","doi-asserted-by":"crossref","first-page":"e63230","DOI":"10.1371\/journal.pone.0063230","article-title":"Calnexin-assisted biogenesis of the neuronal glycine transporter 2 (GlyT2)","volume":"8","author":"Arribas-Gonzalez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib7","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1074\/jbc.M114.587055","article-title":"Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia","volume":"290","author":"Arribas-Gonzalez","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib8","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1523\/JNEUROSCI.17-14-05297.1997","article-title":"ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord","volume":"17","author":"Bardoni","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/mcne.1998.0719","article-title":"The expression of P2X3Purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor","volume":"12","author":"Bradbury","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-007-4719-7_1","article-title":"Introduction to purinergic signalling in the brain","volume":"986","author":"Burnstock","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2013.01.078","article-title":"Purinergic mechanisms and pain\u2013an update","volume":"716","author":"Burnstock","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.2005.088435","article-title":"P2X2 knockout mice and P2X2\/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP","volume":"567","author":"Cockayne","year":"2005","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0031-6997(24)01512-6","article-title":"P2X receptors and nociception","volume":"53","author":"Chizh","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib15","doi-asserted-by":"crossref","first-page":"e58863","DOI":"10.1371\/journal.pone.0058863","article-title":"Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine cluster","volume":"8","author":"de Juan-Sanz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib16","first-page":"434","article-title":"Regulation of the glycinergic neurotransmission during inflammatory pain: a new pathway in the action of Prostaglandin E2 in the spinal cord","volume":"79","author":"de Juan-Sanz","year":"2013","journal-title":"An. La Real Acad. Nac. Farm."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1600-0854.2011.01278.x","article-title":"Endocytosis of the neuronal glycine transporter GLYT2: role of membrane rafts and protein kinase C-dependent ubiquitination","volume":"12","author":"de Juan-Sanz","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2009.03.018","article-title":"Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain","volume":"123","author":"Dohi","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjp.0706887","article-title":"Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues","volume":"149","author":"Ecke","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tibs.2005.04.004","article-title":"Glycine transporters: essential regulators of neurotransmission","volume":"30","author":"Eulenburg","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib21","doi-asserted-by":"crossref","first-page":"31586","DOI":"10.1074\/jbc.M111.247767","article-title":"Naloxone and ouabain in ultralow concentrations restore Na+\/K+-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes","volume":"286","author":"Forshammar","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neuron.2015.02.028","article-title":"Targeted ablation, silencing, and activation establish glycinergic dorsal horn neurons as key components of a spinal gate for pain and itch","volume":"85","author":"Foster","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib23","doi-asserted-by":"crossref","first-page":"17584","DOI":"10.1074\/jbc.M010602200","article-title":"Calcium- and syntaxin 1-mediated trafficking of the neuronal glycine transporter GLYT2","volume":"276","author":"Geerlings","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.bjp.0707217","article-title":"Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization","volume":"151","author":"Gerevich","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1476-5381.2010.00796.x","article-title":"AF-353, a novel, potent and orally bioavailable P2X3\/P2X2\/3 receptor antagonist","volume":"160","author":"Gever","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fncel.2013.00245","article-title":"Desensitization properties of P2X3 receptors shaping pain signaling","volume":"7","author":"Giniatullin","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0896-6273(03)00673-1","article-title":"Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality","volume":"40","author":"Gomeza","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib28","doi-asserted-by":"crossref","first-page":"32793","DOI":"10.1074\/jbc.M104216200","article-title":"The first transmembrane domain of the P2X receptor subunit participates in the agonist-induced gating of the channel","volume":"276","author":"Haines","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1213\/ANE.0b013e3181c7ebbb","article-title":"The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model","volume":"110","author":"Haranishi","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nrd3893","article-title":"Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain","volume":"12","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2008.09.012","article-title":"Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain","volume":"445","author":"Hermanns","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1083\/jcb.143.6.1485","article-title":"Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells","volume":"143","author":"Hirschberg","year":"1998","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00424-006-0063-8","article-title":"Functions of neuronal P2Y receptors","volume":"452","author":"Hussl","year":"2006","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/304730a0","article-title":"ATP excites a subpopulation of rat dorsal horn neurones","volume":"304","author":"Jahr","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-2999(02)01756-9","article-title":"P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system","volume":"447","author":"James","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2008.06.012","article-title":"Purinergic P2X receptors facilitate inhibitory GABAergic and glycinergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus","volume":"1224","author":"Jameson","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tins.2009.10.003","article-title":"The neural-glial purinergic receptor ensemble in chronic pain states","volume":"33","author":"Jarvis","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib38","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1073\/pnas.252537299","article-title":"A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2\/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat","volume":"99","author":"Jarvis","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib39","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy","volume":"36","author":"Jimenez-Pacheco","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib40","doi-asserted-by":"crossref","first-page":"10712","DOI":"10.1074\/jbc.M110.167056","article-title":"P2Y purinergic regulation of the glycine neurotransmitter transporters","volume":"286","author":"Jimenez","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib41","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/sj.bjp.0705865","article-title":"Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation","volume":"142","author":"Joseph","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib42","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/brain\/awq194","article-title":"Systemic blockade of P2X3 and P2X2\/3 receptors attenuates bone cancer pain behaviour in rats","volume":"133","author":"Kaan","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.bjp.0706187","article-title":"Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red","volume":"145","author":"King","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.intimp.2004.01.009","article-title":"Time course and substance P effects on the vascular and morphological changes in adjuvant-induced monoarthritic rats","volume":"4","author":"Lam","year":"2004","journal-title":"Int. Immunopharmacol."},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2017.07.018_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1469-7793.2000.t01-1-00215.x","article-title":"Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors","volume":"522","author":"Laube","year":"2000","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/377432a0","article-title":"Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons","volume":"377","author":"Lewis","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib47","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(24)38849-4","article-title":"Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons","volume":"296","author":"Liu","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib48","doi-asserted-by":"crossref","first-page":"22802","DOI":"10.1016\/S0021-9258(18)41598-0","article-title":"Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features","volume":"268","author":"Liu","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1074\/jbc.M806729200","article-title":"Requirement for aralar and its Ca2+-binding sites in Ca2+ signal transduction in mitochondria from INS-1 clonal \u03b2-cells","volume":"284","author":"M\u00e1rmol","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib50","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.150.3699.971","article-title":"Pain mechanisms: a new theory","volume":"150","author":"Melzack","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/bph.12343","article-title":"Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain","volume":"170","author":"Mingorance-Le Meur","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib52","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1113\/jphysiol.2012.248369","article-title":"Single KATP channel opening in response to stimulation of AMPA\/kainate receptors is mediated by Na+ accumulation and submembrane ATP and ADP changes","volume":"591","author":"Mollajew","year":"2013","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.108.136267","article-title":"Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice","volume":"326","author":"Morita","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2012.00102","article-title":"siRNA design software for a target gene-specific RNA interference","volume":"3","author":"Naito","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib55","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.25.945","article-title":"Regulating factors for microglial activation","volume":"25","author":"Nakamura","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1254\/jphs.09351FP","article-title":"Blockade of glycine transporter (GlyT) 2, but not GlyT1, ameliorates dynamic and static mechanical allodynia in mice with herpetic or postherpetic pain","volume":"112","author":"Nishikawa","year":"2010","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib58","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1523\/JNEUROSCI.15-11-07633.1995","article-title":"Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons","volume":"15","author":"Noguchi","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib59","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.083758","article-title":"P2X receptors as drug targets","volume":"83","author":"North","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib61","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1600-0854.2009.00911.x","article-title":"Subcellular localization of the neuronal glycine transporter GLYT2 in brainstem","volume":"10","author":"Nunez","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib62","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1073\/pnas.91.8.3275","article-title":"Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy","volume":"91","author":"Parr","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1469-7793.2000.t01-1-00471.x","article-title":"ATP facilitates spontaneous glycinergic IPSC frequency at dissociated rat dorsal horn interneuron synapses","volume":"524","author":"Rhee","year":"2000","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib64","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1523\/JNEUROSCI.0628-05.2005","article-title":"Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2\/3, and P2X3 and inhibitory P2Y1, P2Y2, and\/or P2Y4 receptors in the rat hippocampus","volume":"25","author":"Rodrigues","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib65","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1523\/JNEUROSCI.0509-08.2008","article-title":"The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons","volume":"28","author":"Rousseau","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib66","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00418-003-0579-3","article-title":"Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat","volume":"120","author":"Ruan","year":"2003","journal-title":"Histochem Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib67","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1074\/jbc.M116.722330","article-title":"Modulation of P2X3 and P2X2\/3 receptors by monoclonal antibodies","volume":"291","author":"Shcherbatko","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib68","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.neuropharm.2015.08.031","article-title":"Glycine transporter 1 is a target for the treatment of epilepsy","volume":"99","author":"Shen","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/mol.106.023564","article-title":"Experimental and modeling studies of desensitization of P2X3 receptors","volume":"70","author":"Sokolova","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib70","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjp.0705531","article-title":"ATP analogues with modified phosphate chains and their selectivity for rat P2X2 and P2X2\/3 receptors","volume":"140","author":"Spelta","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib71","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/sj.bjp.0705326","article-title":"Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A(2) and is differently regulated by cyclic AMP and Ca(2+)","volume":"139","author":"Strokin","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib72","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10753-016-0323-5","article-title":"A\u00a0novel selective prostaglandin E2 synthesis inhibitor relieves pyrexia and chronic inflammation in rats","volume":"39","author":"Sugita","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0022-510X(66)90047-5","article-title":"Hyperekplexia. A hereditary startle syndrome","volume":"3","author":"Suhren","year":"1966","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/ALN.0b013e31816c9044","article-title":"Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment","volume":"108","author":"Tanabe","year":"2008","journal-title":"Anesthesiology"},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2017.07.018_bib75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-7793.1998.411bn.x","article-title":"The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones","volume":"509","author":"Thomas","year":"1998","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuint.2015.12.007","article-title":"Glycine transporter2 inhibitors: getting the balance right","volume":"98","author":"Vandenberg","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib77","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0026-895X(24)13265-8","article-title":"Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2\/3 receptors","volume":"53","author":"Virginio","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(88)90254-3","article-title":"Origin of ATP release in the rat vas deferens: concomitant measurement of [3H]noradrenaline and [14C]ATP","volume":"158","author":"Vizi","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib79","doi-asserted-by":"crossref","first-page":"9717","DOI":"10.1523\/JNEUROSCI.0381-15.2015","article-title":"Transsynaptic tracing from taste receptor cells reveals local taste receptor gene expression in gustatory ganglia and brain","volume":"35","author":"Voigt","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib80","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1046\/j.1460-9568.1998.00355.x","article-title":"P2X3 is expressed by DRG neurons that terminate in inner lamina II","volume":"10","author":"Vulchanova","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11302-015-9447-6","article-title":"Effect of electroacupuncture on P2X(3) receptor regulation in the peripheral and central nervous systems of rats with visceral pain caused by irritable bowel syndrome","volume":"11","author":"Weng","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12035-007-0033-y","article-title":"P2X3 receptor involvement in pain states","volume":"36","author":"Wirkner","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib83","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.0306707101","article-title":"P2X7 receptors control 2-arachidonoylglycerol production by microglial cells","volume":"101","author":"Witting","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib84","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0005-2736(00)00165-6","article-title":"Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membranes","volume":"1466","author":"Yegutkin","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.07.018_bib86","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1523\/JNEUROSCI.15-05-03952.1995","article-title":"Glycine transporters are differentially expressed among CNS cells","volume":"15","author":"Zafra","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib87","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1460-9568.1995.tb01125.x","article-title":"Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS","volume":"7","author":"Zafra","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib88","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00018-005-5107-2","article-title":"The glycinergic control of spinal pain processing","volume":"62","author":"Zeilhofer","year":"2005","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib89","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cne.20349","article-title":"Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice","volume":"482","author":"Zeilhofer","year":"2005","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.07.018_bib90","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:29:04Z","timestamp":1750782544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817303490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":89,"alternative-id":["S0028390817303490"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}